The Australian government announced last week there's a new vaccine for pneumococcal disease on the National Immunization Program for all children. This vaccine replaces previously listed pneumococcal ...

Pneumococcal pneumonia is a potentially serious illness caused by bacteria called pneumococcus. The illness can disrupt a ...

Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks ...

Add Yahoo as a preferred source to see more of our stories on Google. Less than half (44%) of eligible respondents said they planned to get a pneumococcal vaccine; fewer than one in four (24%) said ...

KIRKLAND, QC, July 29, 2026 /CNW/ — Pfizer Canada ULC is pleased to announce that its 20-valent pneumococcal conjugate ...

The Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and a lung infection called pneumonia. An ...

With an expanded usage recommendation from the CDC's Advisory Committee on Immunization Practices (ACIP), pneumococcal conjugate vaccines from Pfizer and Merck are poised to add millions more eligible ...

French babies who received nirsevimab had lower rates of invasive pneumococcal disease ...

Please provide your email address to receive an email when new articles are posted on . Merck’s 21-valent pneumococcal vaccine Capvaxive was previously approved only for adults. The FDA expanded the ...

The increase in invasive pneumococcal disease across Europe is driven by Streptococcus pneumoniae, which also causes pneumonia and acute otitis media that can progress to invasive infections. Nearly ...